D-807-2013 Class III Terminated

Recalled by Bayer HealthCare Pharmaceuticals Inc. — Morristown, NJ

FDA drug recall D-807-2013 was initiated by Bayer HealthCare Pharmaceuticals Inc. on Jun 13, 2013 and is designated Class III. Reason for recall: Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point. The recall status is terminated (terminated Feb 10, 2014). Affected quantity: 194.62 kg.

Recall details

Product Type
Drugs
Report Date
Jul 24, 2013
Initiation Date
Jun 13, 2013
Termination Date
Feb 10, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
194.62 kg

Product description

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Reason for recall

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Distribution pattern

NY, CA

Code information

Lot 87100040

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-807-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-807-2013. Report a data issue: hello@regdatalab.com.